Dr. Martin Turner

Dr. Martin Turner

Beneficiary (B4)

Martin Turner studied Biochemistry at UCL and did his PhD with Professor Sir Marc Feldmann in London. He worked with Victor Tybulewicz at the MRC National Institute for Medical Research where he identified key signal transduction pathways for B and T lymphocytes. He has been at the BBSRC’s Babraham Institute since 1997. He has uncovered key roles for PI3K in lymphocyte signalling and development. He is interested in RNA-binding proteins and MicroRNAs and how these function within signal transduction networks and DNA transcription factor networks to control cell differentiation and immunity.


The molecular processes which control the development and function of lymphocytes have been extensively studied from the perspective of cell surface receptors and their associated intracellular signalling.

Also, many transcription factors which repress or promote the production of mRNA have been identified as being essential for lymphocyte development and activation.  These studies have revealed that genes, molecules and pathways that are used early in the development of lymphocytes are re-used in fully mature cells as part of the response to infection.

We are developing tools for measuring gene expression in rare cell populations.  We also use genome wide approaches to study RNA turnover and translation and to identify the targets of RNA binding proteins.

We aim to characterise fundamental mechanisms controlling lymphocyte development and function throughout the life-course.  These include understanding the roles of RNA binding proteins in lymphocyte development and activation. 

In the future explaining how these are integrated with signal transduction pathways, microRNA and transcription factor networks will be an important step towards a systems level understanding of immunity.

RNA binding proteins
Signal transduction


© 2018 COSMIC. All Rights Reserved.

Please publish modules in offcanvas position.